A team including corresponding author Associate Professor of Molecular and Integrative Physiology Jongsook Kim Kemper has identified a key molecular player in a chain of events in the body that can lead to fatty liver disease, Type II diabetes and other metabolic abnormalities associated with obesity. By blocking this molecule, the researchers were able to reverse some of the pathology it caused in obese mice. Their findings appear in the Proceedings of the National Academy of Sciences.

Related topics: